|
Thu, 07/11/2024 - 18:27 |
Targeted drug treatment leads tumor cells to imitate viral infection |
Broad Institute |
|
Sun, 04/19/2020 - 20:26 |
AI may help brain cancer patients avoid biopsy |
UTSouthwestern |
|
Wed, 02/13/2019 - 12:38 |
Study unveils a blueprint for treating a deadly brain tumor |
NIH |
|
Tue, 08/01/2017 - 12:42 |
FDA Grants Approval of IDHIFA, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation |
BMS |
|
Mon, 07/10/2017 - 16:47 |
PhD Student Explores Enzymes Role in Aggressive Brain Tumor |
Northwestern Un... |
|
Tue, 06/06/2017 - 10:00 |
Updated Data from Phase 1 Trial of Oral IDHIFA (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation |
BMS |
|
Tue, 04/04/2017 - 07:32 |
IDH-mutant Cancers May be More Amenable to PARP Inhibitors Than IDH Inhibitors |
American Associ... |
|
Wed, 10/12/2016 - 10:02 |
Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML |
BMS |
|
Wed, 12/23/2015 - 08:02 |
Genome misfolding unearthed as new path to cancer |
Broad Institute |
